BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 24497229)

  • 1. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Bhatt J
    Cochrane Database Syst Rev; 2014 Feb; (2):CD002009. PubMed ID: 24497229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Bhatt J; Nevitt SJ
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD002009. PubMed ID: 28349527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Bhatt J; Jahnke N; Smyth AR
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD002009. PubMed ID: 31483853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Bhatt J
    Cochrane Database Syst Rev; 2010 Jan; (1):CD002009. PubMed ID: 20091528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Tan KH
    Cochrane Database Syst Rev; 2006 Jul; (3):CD002009. PubMed ID: 16855982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Bhatt J
    Cochrane Database Syst Rev; 2012 Feb; (2):CD002009. PubMed ID: 22336782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once daily versus multiple daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Tan K; Bunn H
    Cochrane Database Syst Rev; 2000; (4):CD002009. PubMed ID: 11034740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.
    Elphick HE; Scott A
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD002007. PubMed ID: 27907224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.
    Holland P; Jahnke N
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD002007. PubMed ID: 34159577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis.
    Elphick HE; Jahnke N
    Cochrane Database Syst Rev; 2014 Apr; (4):CD002007. PubMed ID: 24788768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis.
    Elphick HE; Tan A
    Cochrane Database Syst Rev; 2005 Apr; (2):CD002007. PubMed ID: 15846627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.
    Hurley MN; Smith S; Forrester DL; Smyth AR
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD008037. PubMed ID: 32671834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
    Smith S; Rowbotham NJ; Charbek E
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD008319. PubMed ID: 30376155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis.
    Lands LC; Stanojevic S
    Cochrane Database Syst Rev; 2016 Apr; 4():CD001505. PubMed ID: 27055154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
    Smith S; Rowbotham NJ; Charbek E
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD008319. PubMed ID: 35914011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of intravenous antibiotic therapy in people with cystic fibrosis.
    Plummer A; Wildman M
    Cochrane Database Syst Rev; 2013 May; (5):CD006682. PubMed ID: 23728662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD006961. PubMed ID: 28628280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD005405. PubMed ID: 27412131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.